Translation. Region: Russian Federal
Source: Novosibirsk State University –
An important disclaimer is at the bottom of this article.
The VII All-Russian Conference "Tumor Markers: Molecular, Genetic and Clinical Aspects" was held in Novosibirsk from July 28 to 30, 2025. The event brought together more than a hundred leading Russian specialists: opinion leaders, professors of the Russian Academy of Sciences, heads of molecular laboratories, heads of clinical departments and diagnostic centers. The central topic of discussion was the transformative role of bioinformatics in the search for new biomarkers, the development of personalized methods for diagnosing and treating cancer. Institute of Medicine and Medical Technologies of NSU (IMMT NSU) The event was presented by the head of the biotechnology and medicine department, Maria Lomova, and the head of the bioinformatics laboratory, Alexander Vikhorev.
The conference confirmed the status of bioinformatics as one of the most dynamic and sought-after scientific disciplines in modern oncology. Participants unanimously noted that without complex big data analysis, machine learning and artificial intelligence (AI), further breakthroughs in understanding the mechanisms of oncogenesis and creating effective diagnostic tools are impossible.
The event became a unique platform for the formation of scientific and practical cooperation between bioinformaticians, molecular biologists and clinicians. Only the joint work of these specialists allows us to translate fundamental discoveries in the field of tumor markers into real clinical protocols.
The conference actively discussed advanced bioinformatic approaches for searching and validating new biomarkers in genomic data, platform solutions for determining the mutational status of patients. A special focus was made on the use of AI in oncology research. Participants shared their experience in using AI to analyze medical images, gene expression patterns, predict drug resistance, and develop individual treatment regimens.
— The conference clearly demonstrated that bioinformatics has ceased to be an auxiliary tool — it has become the driving force of oncological research. It is bioinformaticians, who possess methods for analyzing the most complex genomic data, who today decipher the "language" of cancer, helping to find new targets for therapy and create tests for early diagnostics. For young scientists and students, this is an area of enormous opportunities and a real contribution to saving lives, — noted Alexander Vikhorev.
The participants of the event noted that the VII All-Russian Conference "Tumor Markers" in Novosibirsk successfully fulfilled its task, providing specialists of different profiles with an important platform for professional dialogue. The exchange of relevant experience and views on the application of modern approaches will undoubtedly contribute to the development of more effective solutions in the field of oncology. The example of IMMT NSU shows that participation in such events remains significant for the scientific community and practical healthcare.
Please note: This information is raw content obtained directly from the source of the information. It is an accurate report of what the source claims and does not necessarily reflect the position of MIL-OSI or its clients.
.